Not an SEC registrant

Lonza AG

Customers

1 disclosed

Suppliers

None disclosed

Largest customer

—

No % disclosed

Named-customer revenue

—

No estimate available

Latest period

Dec 31, 2025

20-F filed 2026-02-11

Thicker bands are larger estimated dollar flows. Supplier percentages are a share of the supplier's revenue; customer percentages are a share of Lonza AG's. Dashed links are named without a figure, so their size says nothing. Click a band for its source.

How this is estimated

Dollars are the disclosed share × the discloser's revenue for that period, using the latest full year where available, or federal dollars obligated. Each side has its own scale.

Customers 1

Companies that buy from Lonza AG, as either company disclosed it. Percentages are a share of Lonza AG revenue. 1 active, 0 lapsed.

Company	% of Lonza AG revenue	Est. revenue	Period	Trend	Status	Source
ASND Ascendis Pharma A/S	Named	—	FY 2025-12-31	—	Active	20-F 2026-02-11
Our growth hormone parent drug as well as our TransCon hGH drug substance are supplied by both Fujifilm Diosynth Biotechnologies UK Limited (“Fujifilm”), and Lonza Ltd. Our PTH as well as our TransCon PTH drug substance is supplied by Bachem, Switzerland, pursuant to our agreement with Bachem. 20-F filed 2026-02-11 Period FY 2025-01-01 to 2025-12-31Accession 0001193125-26-046590

Alerts are coming

Get an email when Lonza AG's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.